Factores de riesgo y prevalencia de trastornos migrañosos en población adulta. Estrategias médicas desde la atención primaria comunitaria

Elizabeth  Salas Acosta; Mireya  Salas de González; Melissa  González-Salas

doi:10.17162/rccs.v14i1.1477

Authors

Elizabeth Salas Acosta Universidad del Zulia, Zulia, Venezuela https://orcid.org/0000-0003-0496-968X
Mireya Salas de González Centro de Investigaciones y desarrollo de Bioingeniería de la Costa Oriental del Lago (CIDIBICOL-UPTZ) https://orcid.org/0000-0001-7740-8723
Melissa González-Salas Centro de Asesorias Educativas CEASE, Zulia, Venezuela https://orcid.org/0000-0003-0686-1285

DOI:

https://doi.org/10.17162/rccs.v14i1.1477

Keywords:

Risk factors, migraine disorders, primary health care.

Abstract

Objective: To determine the risk factors for migraine disorders, present in the adult population towards
the establishment of medical strategies for their prevention and treatment from community primary
care. Methodology: The study was developed through a descriptive and field type investigation, with
a sample of 64 patients, determined through an intentional non-probabilistic sampling. A Questionnaire
was designed as a data collection instrument, whose content validation by means of nine experts was
sufficient. In the statistical treatment, Excel 2007 and SPSS version 23 were used, with a descriptive
procedure of frequencies, summations, arithmetic mean and percentages, represented in frequency
tables by indicators. Results: The prevalence of a family history of migraine is demonstrated, while
the characteristics of the pain were hemicranial, throbbing, moderate intensity, insidious, evolution over
5 years, naproxen being the most widely used drug. Prevalence of migraine without aura in females
between the ages of 31 to 60 years. The most experienced symptom besides pain was vomiting /
nausea. Conclusion: According to the results, it is concluded that the greatest triggering risk factor
for migraine was environmental factors, translated into high thermal sensation. The application of local
strategy guidelines in health promotion and prevention is recommended.

Downloads

Download data is not yet available.

References

Artigas-Pallarés J; Grau, R.; Esclusa, F.; Canosa, P
y Moltó, E. (1998). “Prevalencia y características
de la cefalea y la migraña en la infancia”. Rev
Neurol; vol.26 (151): 368-371. Recuperado de:
https://www.neurologia.com/articulo/98952
Cady RK (2014). “Red flags and comfort signs for
ominous secondary headaches”. Otolaryngol Clin
N Am 2014; Apr 47 (2):289-299. doi: 10.1016/j.
otc.2013.10.010.
Chávez, N. (2003). Introducción a la Investigación
Educativa. Maracaibo:
Ezpeleta D. (2007). “Diagnóstico diferencial de
la cefalea en urgencias” Jano: Medicina y
Humanidades 2007; 1662: 31-35.
Goadsby PJ.(2012) “Pathophysiology of migraine”.
Ann Indian Acad Neurol. 2012 Aug; 15 (Suppl 1):
S15–S22. DOI: 10.4103/0972-2327.99993
Hernández, R. Fernández, C. & Baptista, P. (2010).
Metodología de la Investigación. 5ª ed. México,
DF & Mc. Graw Hill.
Larrosa-Campo, D.; Ramón-Carbajo, C.; Para-Prieto,
M.; Calleja-Puerta, S.; Cernuda-Morollón, E. y
Pascual, J. (2012). “La migraña como factor de
riesgo vascular”. Rev Neurol 2012; 55 (6): 349-
358.
Martin V, E. (2004). “Diagnosis and classification
of primary headache disorders”. In: Standards
of care for headache diagnosis and treatment.
Chicago (IL): Rev. National Headache Foundation;
2004. p. 4-18.
Martínez, L. (2004) Epidemiología de la migraña
en adolescentes. Tesis de postgrado de
Neuropediatría. Barquisimeto: Universidad
Centro occidental Lisandro Alvarado.
McCandless RT, Arrington CB, Nielsen DC, Bale JF
y Minich LLA. (2011). “Patent Foramen Ovale
in Children with Migraine Headaches”. The
Journal Pediatrics. August 2011 Volume 159,
Issue 2: 243–247. DOI: https://doi.org/10.1016/j.
jpeds.2011.01.062
Organización mundial de la Salud (OMS, 2008).
Trastornos neurológicos. Desafíos para la
salud pública. Documento en línea. [acceso
15 septiembre 2019]. Disponible en: www1.
paho.org/hq/dmdocuments/2008/Trastornos_
Neurologicos.pdf
Oterino, A. y Pascual, J. (2008). “Genética de la
migraña” Acta Neurol Colomb 2008. Vol. 24 No.
3 Suplemento (3:1) pp. 34-43. Septiembre 2008
https://www.acnweb.org/acta/2008_24_S3_34.
pdf
Padua, J. (2002) Técnicas de Investigación aplicadas
a las Ciencias Sociales. México: Fondo de
Cultura Económica
Pascual J. (2012). “Migraña crónica: tratamiento”.
Rev Neurol 2012; 54 (Supl 2): S31-68. https://
psyciencia.com/wp-content/uploads/2012/10/
tratamiento-migrana1.pdf
Pérez, R. (2007) “Migraña. Tratamiento”. Revista
científica Portales Médicos. Vol II. Nº13,
Septiembre, 2007. España
Silberstein, S. (2004). “Migraine pathophysiology and
its clinical implications”. Cephalalgia. 2004; 24
(Suppl 2): S2-7.
Terwindt, GM.; Ophoff, RA.; Haan, J.; Sandkuijl, LA.;
Frants, R. y Ferrari, MD. (1998). “Migraine, ataxia
and epilepsy: a challenging spectrum of genetic
determined calcium channelopathies”. Eur J Hum
Genet Jul-Aug 1998;6(4):297-307. doi: 10.1038/
sj.ejhg.5200206.
Titus, F; Fraga, C. y Martínez, J. (1992). Clasificación
y criterios diagnósticos de las cefaleas, las
neuralgias craneales y el dolor facial. Barcelona:
MCR.
Uribe García, B. (2008). “Impacto de la migraña”.
Acta Neurol Colomb Vol. 24 No. 3 Suplemento
(3:1) septiembre 2008. https://www.acnweb.org/
acta/2008_24_S3_28.pdf
Vicente, M. (2008). La migraña. Su impacto y
repercusión laboral. Tesis de grado publicada.
España: Universidad de Valencia. http://hdl.
handle.net/10803/10078